Heart Transplantation After Donation After Circulatory Death: Early United States Experience

Syed Shahyan Bakhtiyar1, Sara Sakowitz2, Saad Mallick2

  • 1Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California; Department of Surgery, University of Colorado, Aurora, Colorado.

PubMed

Insights

Heart transplants using donation after circulatory death (DCD) donors are increasing. DCD heart transplants show survival rates comparable to donation after brain death (DBD) up to three years, supporting expanded donor use.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Organ Donation

Background:

  • Renewed interest in heart transplantation utilizing donation after circulatory death (DCD) donors.
  • Need for contemporary analysis of trends and long-term survival in DCD heart transplantation.

Purpose of the Study:

  • To analyze trends in DCD heart transplantation.
  • To compare posttransplant survival rates between donation after brain death (DBD) and DCD heart recipients.

Main Methods:

  • Adult heart transplant recipients from December 2019 to September 2023 identified in the Organ Procurement and Transplantation Network.
  • Stratification of recipients into DBD or DCD groups, with DCD further classified into direct procurement and perfusion (DCD-DPP) or normothermic regional perfusion (DCD-NRP).
  • Primary outcome was 1- and 3-year posttransplant survival.

Main Results:

  • 7% (792 of 11,625) of heart transplants involved DCD allografts, with a significant increase in DCD use from 2% to 11% between December 2019 and September 2023.
  • Adjusted analysis revealed similar 1-year and 3-year posttransplant survival for DBD recipients compared to both DCD-DPP and DCD-NRP recipients.
  • Incidence of postoperative stroke, dialysis, acute graft rejection, and primary graft dysfunction were comparable across all groups.

Conclusions:

  • The utilization of DCD heart transplantation is rising.
  • DCD and DBD heart recipients demonstrate equivalent posttransplant survival up to three years across diverse recipient risk and center volume categories.
  • These findings support the expanded use of DCD donors to increase the available organ pool for heart transplantation.
Abstract